PDS Biotechnology Corporation (PDSB) Financials

$1.33

$0.06 (4.72%)
Last update: 01:00 PM EST
Day's range
$1.26
Day's range
$1.34
$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40M-$50M-$50MEarning201820182019201920202020202120212022202220232023202420245%5%4%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

PDSB Income statement / Annual

Last year (2024), PDS Biotechnology Corporation's total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, PDS Biotechnology Corporation's net income was -$37.61 M. See PDS Biotechnology Corporation,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $59.79 K $57.33 K $49.08 K $246.39 K $176.29 K $98.41 K $69.12 K $182.92 K $100.12 K $53.12 K
Gross Profit -$59.79 K -$57.33 K -$49.08 K -$246.00 K -$176.00 K -$98.41 K -$69.12 K -$183.00 K -$100.00 K -$53.12 K
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $22.57 M $27.76 M $29.43 M $11.26 M $7.92 M $6.10 M $830.74 K $34.31 M $24.83 M $17.84 M
General & Administrative Expenses $0.00 $15.02 M $12.24 M $10.19 M $6.96 M $10.98 M $14.29 M $17.66 M $14.69 M $8.66 M
Selling & Marketing Expenses $0.00 $264.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $13.70 M $15.28 M $12.24 M $10.19 M $6.96 M $10.98 M $14.29 M $17.66 M $14.69 M $8.66 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $15.61 K $3.95 B $12.74 B $0.00 -$163.46 K -$1.88 M
Operating Expenses $36.26 M $43.05 M $41.67 M $21.44 M $14.73 M $15.41 M $3.65 M $51.97 M $39.51 M $26.50 M
Cost And Expenses -$36.32 M $43.05 M $41.67 M $21.44 M $14.90 M $21.03 M $30.36 M $51.97 M $39.51 M $26.50 M
Interest Income $2.52 M $2.90 M $935.18 K $4.35 K $55.01 K $353.49 K $871.88 K $700.90 K $212.30 K $9.08 K
Interest Expense $4.67 M $4.21 M $1.32 M $0.00 $0.00 $33.56 K $1.43 M $2.18 M $1.20 M $816.49 K
Depreciation & Amortization $59.79 K $57.33 K $49.08 K $246.39 K $176.29 K $98.41 K $69.12 K $182.92 K $100.12 K $53.12 K
EBITDA -$33.75 M -$40.09 M -$40.69 M -$21.19 M -$14.67 M -$16.98 M -$3.58 M -$51.08 M -$39.36 M -$28.32 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net -$2.16 M -$1.30 M -$381.34 K $4.35 K $0.00 $13.65 M $0.00 $0.00 -$259.65 K -$2.69 M
Income Before Tax -$38.48 M -$44.35 M -$42.05 M -$21.44 M -$14.85 M -$7.38 M -$3.84 M -$53.45 M -$40.67 M -$29.19 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense -$869.00 K -$1.41 M -$1.20 M -$4.52 M -$136.00 K -$382.00 K -$2.78 M -$2.59 M $0.00 -$1.11 M
Net Income -$37.61 M -$42.94 M -$40.86 M -$16.92 M -$14.85 M -$7.00 M -$40.87 M -$50.86 M -$38.82 M -$28.08 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -1079.45 -1.39 -1.43 -0.66 -0.89 -1.44 -26.16 -33.47 -26.9 -69.43
EPS Diluted -1079.45 -1.39 -1.43 -0.66 -0.89 -1.44 -26.16 -33.47 -26.9 -69.43
Weighted Average Shares Out $36.45 M $30.95 M $28.60 M $25.60 M $16.75 M $4.87 M $166.87 K $1.52 M $1.44 M $404.40 K
Weighted Average Shares Out Diluted $36.45 M $30.95 M $28.60 M $25.60 M $16.75 M $4.87 M $166.87 K $1.52 M $1.44 M $404.40 K
Link